Viewing Study NCT00161668


Ignite Creation Date: 2025-12-24 @ 5:59 PM
Ignite Modification Date: 2026-01-22 @ 4:21 PM
Study NCT ID: NCT00161668
Status: COMPLETED
Last Update Posted: 2007-03-15
First Post: 2005-09-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module